Welcome to Sanzyme, we are amongst the
first to offer contract manufacturing of
human-derived Gonadotropins, for the world.
It is possible because we’ve been making Gonadotropins for over a half century.
Welcome to Sanzyme, we are amongst the first to offer contract manufacturing of human-derived Gonadotropins, for the world. It is possible because we’ve been making Gonadotropins for over a half century.
Our experience in the 3 Cs - Certifications, CTDs and our Capacity puts us in a unique position as a collaborator and partner in success for many of the world’s leading pharmaceutical brands.
sanzyme-1
sanzyme-1
sanzyme-2

EU GMP CERTIFIED

DOSSIERS IN e-CTDs

CAPACITY OF 10+ MILLION VIALS / PER ANNUM

Globally, we help couples and prospective parents with our Infertility Drugs, and today our portfolio also includes Sex Hormones and Specialty Probiotics. We are widely regarded for our pioneering work in the IVF and Assisted Reproductive Technology space.

MILESTONES

1969
Founded as Uni Sankyo, First Indo-Japanese Joint Venture
1978
Established extraction plant of HCG intermediate from pregnant women urine
1979
Established the First Pharma Injectable plant
1999
Launch of Second Hormone Injectable plant
2000
New Biological Laboratory set up
2000
Launch of Menotropin & Urofollitropin Injections
2005
New First Purification plant: R&D Laboratory
2010
40 years of association with Sankyo, Japan
2013
Third New formulation Injectable plant for gonadotropins exclusively
2015
EU GMP for Formulation plant
2020
New Second Drug Substance plant (Purification Plant)

OUR PRESENCE

Currently we operate in emerging markets with our distribution partners and in house brands.

We are open for Out Licensing / Co-development / other models of collaboration, as we expand our footprints to highly regulated markets.

We at Sanzyme are fully aware and prepared of dynamic regulatory landscape in the segment of Biologics/Biosimilars.

Armed with EU GMP & PIC/s for our Finished Formulations, we offer our e-CTD to cater to global regulatory requirements.

Play Video
Corporate Communication and...

RECENT NEWS

Visited 30,931 times, 5 visit(s) today
Close Search Window
Close